Evaluation of the inhibitory effect of 2,5-Dimethyl-Celecoxib on tamoxifen-sensitive and -resistant human breast cancer cells (MCF-7). (2026). Clinical Medicine and Pharmacology, 3(1). https://doi.org/10.70731/sh45n436